266 related articles for article (PubMed ID: 16866356)
1. New insights into the inhibition of human neutrophil elastase by heparin.
Spencer JL; Stone PJ; Nugent MA
Biochemistry; 2006 Aug; 45(30):9104-20. PubMed ID: 16866356
[TBL] [Abstract][Full Text] [Related]
2. Heparin and its derivatives modulate serine proteinases (SERPS) serine proteinase inhibitors (SERPINS) balance. Physiopathological relevance.
Hornebeck W; Lafuma C; Robert L; Móczár M; Móczár E
Pathol Res Pract; 1994 Oct; 190(9-10):895-902. PubMed ID: 7899138
[TBL] [Abstract][Full Text] [Related]
3. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
Hausser H; Kresse H
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
[TBL] [Abstract][Full Text] [Related]
4. Chemical constituents from the leaves of Ilex paraguariensis inhibit human neutrophil elastase.
Xu GH; Kim YH; Choo SJ; Ryoo IJ; Yoo JK; Ahn JS; Yoo ID
Arch Pharm Res; 2009 Sep; 32(9):1215-20. PubMed ID: 19784576
[TBL] [Abstract][Full Text] [Related]
5. Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G.
Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
Biochem Pharmacol; 2006 Jan; 71(3):287-93. PubMed ID: 16310171
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings.
Edwards JV; Howley P; Cohen IK
Int J Pharm; 2004 Oct; 284(1-2):1-12. PubMed ID: 15454291
[TBL] [Abstract][Full Text] [Related]
7. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.
Yu H; Tyrrell D; Cashel J; Guo NH; Vogel T; Sipes JM; Lam L; Fillit HM; Hartman J; Mendelovitz S; Panel A; Roberts DD
Arch Biochem Biophys; 2000 Feb; 374(1):13-23. PubMed ID: 10640391
[TBL] [Abstract][Full Text] [Related]
8. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
Belorgey D; Bieth JG
Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
Durham SL; Hare CM; Angelastro MR; Burkhart JP; Koehl JR; Marquart AL; Mehdi S; Peet NP; Janusz MJ
J Pharmacol Exp Ther; 1994 Jul; 270(1):185-91. PubMed ID: 8035315
[TBL] [Abstract][Full Text] [Related]
10. Tailoring elastase inhibition with synthetic peptides.
Vasconcelos A; Azoia NG; Carvalho AC; Gomes AC; Güebitz G; Cavaco-Paulo A
Eur J Pharmacol; 2011 Sep; 666(1-3):53-60. PubMed ID: 21658384
[TBL] [Abstract][Full Text] [Related]
11. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of the complex of non-peptidic inhibitor of human neutrophil elastase ONO-6818 and porcine pancreatic elastase.
Odagaki Y; Ohmoto K; Matsuoka S; Hamanaka N; Nakai H; Toda M; Katsuya Y
Bioorg Med Chem; 2001 Mar; 9(3):647-51. PubMed ID: 11310599
[TBL] [Abstract][Full Text] [Related]
13. A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase.
Steinbrecher T; Case DA; Labahn A
J Med Chem; 2006 Mar; 49(6):1837-44. PubMed ID: 16539369
[TBL] [Abstract][Full Text] [Related]
14. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites.
Mitsi M; Hong Z; Costello CE; Nugent MA
Biochemistry; 2006 Aug; 45(34):10319-28. PubMed ID: 16922507
[TBL] [Abstract][Full Text] [Related]
15. Modulation of elastase binding to elastin by human alveolar macrophage-derived lipids.
Fujita J; Sköld CM; Daughton DM; Ertl RF; Takahara J; Rennard SI
Am J Respir Crit Care Med; 1999 Sep; 160(3):802-7. PubMed ID: 10471600
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobic interactions are involved in the inhibition of human leukocyte elastase by alkyltrimethylammonium salts.
Kouadri-Boudjelthia A; Wallach JM
Int J Biochem Cell Biol; 1997 Feb; 29(2):353-9. PubMed ID: 9147137
[TBL] [Abstract][Full Text] [Related]
17. Natural compounds as inhibitors of human neutrophil elastase.
Siedle B; Hrenn A; Merfort I
Planta Med; 2007 May; 73(5):401-20. PubMed ID: 17447201
[TBL] [Abstract][Full Text] [Related]
18. Structures of human proteinase 3 and neutrophil elastase--so similar yet so different.
Hajjar E; Broemstrup T; Kantari C; Witko-Sarsat V; Reuter N
FEBS J; 2010 May; 277(10):2238-54. PubMed ID: 20423453
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte elastase hydrolysis of peptides derived from human elastin exon 24.
Lombard C; Arzel L; Bouchu D; Wallach J; Saulnier J
Biochimie; 2006 Dec; 88(12):1915-21. PubMed ID: 16945464
[TBL] [Abstract][Full Text] [Related]
20. Ahp-Cyclodepsipeptides as tunable inhibitors of human neutrophil elastase and kallikrein 7: Total synthesis of tutuilamide A, serine protease selectivity profile and comparison with lyngbyastatin 7.
Chen QY; Luo D; Seabra GM; Luesch H
Bioorg Med Chem; 2020 Dec; 28(23):115756. PubMed ID: 33002682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
